Employed 2021
Born: 1971
Education: MSc in Business, Uppsala University, Sweden and MBA Suffolk University, USA
Background: Various management positions within Amgen and broad consulting experience from McKinsey and Ernst & Young
Other assignments: –
Shareholdings: 17 620 B shares as personal holdings and 432 277 call options
Employed 2019
Born: 1972
Education: MD PhD at Karolinska Institutet, Stockholm
Background: Specialist in anaesthesia and intensive care, Karolinska University Hospital. Medical officer, CSL Behring
Other assignments: –
Shareholdings: 9,850 B shares as personal holdings and 28 818 call options
Employed 2022
Born: 1974
Education: MSc in Economics Linnaeus University
Background: CFO positions at, among others, Stille, Sivers IMA and Rolling Optics
Other assignments:
Shareholdings: 144 092 call options
Employed 2021
Born: 1966
Education: MBA University of Stockholm
Background: Global Marketing Director Mölnlycke Health Care, Country Director Doro Care, Head of Sales and Marketing Mundipharma, Country Director Doro Care, Sales and Marketing Director Aleris, VD Orthocenter Göteborg/Malmö
Other assignments: –
Shareholdings: 144 092 call options
Employed 2013
Born: 1979
Education: BSc (Chemistry), University of Malaya & Master of Business Administration, Cardiff Metropolitan University, United Kingdom.
Background: Different managerial positions within Teleflex Medical and C.R. Bard.
Other assignments: Board member of Vigilenz Medical Devices Sdn Bhd and Vigilenz Medical Supplies Sdn Bhd.
Shareholdings: 144 092 call options
Employed 2021
Born: 1967
Education: Bachelor’s degree in marketing, IHM Gothenburg
Background: Various Sales Manager positions within MedTech companies such as Straumann group, Biomet 3i (now part of Zimmer Biomet) and Dentsply.
Other assignments:
Shareholdings: 3,100 B shares as personal holdings and 144 092 call options
Employed 2021
Born: 1968
Education: Biochemistry and Molecular Biology – Bachelor degree
Background: Long experience from different managerial positions and consultancies within “Life Science”
Other assignments: –
Shareholdings: 14 409 B shares